Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M B Tyers

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
British Journal of Pharmacology|February 1, 1989
Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouseB Costall, M E Kelly, R J Naylor, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1990
[3H] GR67330, a very high affinity ligand for 5-HT3 receptorsG J Kilpatrick, A Butler, R M Hagan, et al.
British Journal of Pharmacology|March 1, 1992
The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the ratP J Birch, S M Harrison, A G Hayes, et al.
Nature|April 27, 1989
5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueJ M Barnes, N M Barnes, B Costall, et al.
Progress in Medicinal Chemistry|January 1, 1992
Ondansetron and related 5-HT3 antagonists: recent advancesA W Oxford, J A Bell, G J Kilpatrick, et al.
Anaesthesia|January 1, 1975
Human placental transfer of AH8165C E Blogg, B R Simpson, M B Tyers, et al.
British Journal of Pharmacology|May 1, 1989
5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferretG A Higgins, G J Kilpatrick, K T Bunce, et al.
European Journal of Pharmacology|December 16, 1986
Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscleM A Blank, J R Brown, J C Hunter, et al.
British Journal of Pharmacology|April 1, 1991
The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonistC A Halliday, B J Jones, M Skingle, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
The effect of ondansetron on cognitive performance in the marmosetA M Domeney, B Costall, P A Gerrard, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
British Journal of Pharmacology|February 1, 1989
Neuroanatomical sites of action of 5-HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouseB Costall, M E Kelly, R J Naylor, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1990
[3H] GR67330, a very high affinity ligand for 5-HT3 receptorsG J Kilpatrick, A Butler, R M Hagan, et al.
British Journal of Pharmacology|March 1, 1992
The non-peptide NK1 receptor antagonist, (+/-)-CP-96,345, produces antinociceptive and anti-oedema effects in the ratP J Birch, S M Harrison, A G Hayes, et al.
Nature|April 27, 1989
5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissueJ M Barnes, N M Barnes, B Costall, et al.
Progress in Medicinal Chemistry|January 1, 1992
Ondansetron and related 5-HT3 antagonists: recent advancesA W Oxford, J A Bell, G J Kilpatrick, et al.
Anaesthesia|January 1, 1975
Human placental transfer of AH8165C E Blogg, B R Simpson, M B Tyers, et al.
British Journal of Pharmacology|May 1, 1989
5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferretG A Higgins, G J Kilpatrick, K T Bunce, et al.
European Journal of Pharmacology|December 16, 1986
Effects of VIP and related peptides and Gila monster venom on genitourinary smooth muscleM A Blank, J R Brown, J C Hunter, et al.
British Journal of Pharmacology|April 1, 1991
The pharmacology of fluparoxan: a selective alpha 2-adrenoceptor antagonistC A Halliday, B J Jones, M Skingle, et al.
Pharmacology, Biochemistry, and Behavior|January 1, 1991
The effect of ondansetron on cognitive performance in the marmosetA M Domeney, B Costall, P A Gerrard, et al.
Pageof 9